I always keep in mind the phase 3 trial is due in between 2022-2024 even before the covid delay. See the attached announcement released on 28/04/20.
PAR just reinstated this timeframe in the conference and being conservatives that the worse case scenario which 2nd endpoint to be started after the1st, so 18+12=30months. If FDA feedback approved both trials can be run concurrently then 2022 will be the earliest. To me, I think PAR just play safe on a timeframe before any FDA feedback. (FDA should be very busy with the covid vaccine meeting which due this week)
Don't be over reacted and what if FDA approved the 2022 scenario next week? 50% rally on the R&D day?
DYOR
I always keep in mind the phase 3 trial is due in between...
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
-0.005(2.13%) |
Mkt cap ! $80.45M | |||
| Open | High | Low | Value | Volume |
| 23.8¢ | 24.0¢ | 23.0¢ | $124.1K | 527.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 32320 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 28026 | 2 |
View Market Depth
| Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |